Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018). Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science, 361(6408), eaau1184
Jutkowitz, Eric, Fernando Alarid-Escudero, Karen M. Kuntz, and Hawre Jalal. "The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis." PharmacoEconomics 37, no. 7 (2019): 871-877.
Alarid-Escudero, Fernando, Eva A. Enns, Karen M. Kuntz, Tzeyu L. Michaud, and Hawre Jalal. “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier." Value in Health 22, no. 5 (2019): 611-618.
Jutkowitz, Eric, Fernando Alarid-Escudero, Karen M. Kuntz, and Hawre Jalal. "The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis." PharmacoEconomics 37, no. 7 (2019): 871-877.
Jalal, H., & Alarid-Escudero, F. (2018). A Gaussian approximation approach for value of information analysis. Medical Decision Making, 38(2), 174-188.
Jutkowitz E, Alarid-Escudero F, Choi H, Kuntz K, Jalal H. Value of information analyses of gout therapies: Using a meta-modeling approach. PharmacoEconomics. In Press (2017).
Jalal, H., Pechlivanoglou, P., Krijkamp, E., Alarid-Escudero, F., Enns, E., & Hunink, M. M. (2017). An Overview of R in Health Decision Sciences. Medical Decision Making.
Chen, B. K.,
Jalal, H., Hashimoto, H., Suen, S. C., Eggleston, K., Hurley, M., Bhattacharya, J. Forecasting Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan. The Journal of the Economics of Ageing. 2016. Accepted, and National Bureau of Economic Research (No. w21870).
Jalal, H., O'Dell, J. R., Bridges, S. L., Cofield, S., Curtis, J. R., Mikuls, T. R., Moreland, L. W., Michaud, K. Cost-Effectiveness of Triple Therapy versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis. Arthritis care & research. 2016.
Michaud, T. L., Abraham, J., Jalal, H. J., Luepker, R. V., Duval, S., & Hirsch, A. T.. Cost-effectiveness of a statewide campaign to promote aspirin use for primary prevention of cardiovascular disease. Journal of the American Heart Association. 2015. 4(12), e002321.
Goldhaber-Fiebert J, Jalal H. Some health states are certainly better than others: Using health state rank order to improve probabilistic sensitivity analyses. Medical Decision Making. 2015. 0272989X15605091.
Jalal H, Goldhaber-Fiebert J, Kuntz KM. Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling, Medical Decision Making (Online 2015).
Leung TI, Jalal HJ, Zulman DM, Dumontier M, Owens DK, Musen MA, Goldstein MK. “Automating Identification of Multiple Chronic Conditions in Clinical Practice Guideline Recommendations.” JAMIA Proceedings, 2015.
Jalal H, Dowd B, Sainfort F, Kuntz KM. Linear regression metamodeling as a tool to summarize and present simulation model results. Med Decis Making 2013;7:880-890.
Wang SY, Chu H, Shamliyan T, Jalal H, Kuntz KM, Kane R, Virnig B. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst. 2012;104:507–516.
Nyman J, Jalal H. Including indirect medical care costs from survivor years of life in economic evaluations. PharmacoEconomics. 2011;29:173-174.